Tuesday, October 4, 2016

Flu Vaccines A reprint

I don't do this often, but I found this to be pretty spectacular. So this woman gives very credible arguments for not getting the flu vaccine. It's a multi multi billion dollar business with no viable efficacy. It's never been proven they work. Read it, it's very well done.  And wait, look, there are initials after name. Some think that's more important than anything else in the world.

Flu Vaccines Part I
 by Pamela A. Popper, Ph.D., N.D.
It’s fall, the time when health authorities, medical doctors, and government officials start aggressively promoting flu vaccines for everyone. My advice - just say “no.”
Marketing the flu vaccine to the public requires a lot of misrepresentation, which includes overstating the incidence and risks associated with the flu. The flu virus is constantly present and does not make a brief appearance during “flu season.” Influenza is often confused with influenza-like illness (ILI) which can result from 200 viruses in addition to influenza A and B.  These viruses produce the same symptoms as flu, which include fever, headache, aches, pains, cough, and runny noses, making it impossible to distinguish between the two without diagnostic testing. An individual is seven times more likely to have an influenza-like illness than influenza, but ILI is rarely serious.
Nonetheless The Centers for Disease Control promotes flu vaccines, stating, “Influenza is a serious disease that can lead to hospitalization and sometimes even death. Every flu season is different, and influenza infection can affect people differently. Even healthy people can get very sick from the flu and spread it to others. Over a period of 31 seasons between 1976 and 2007, estimates of flu-associated deaths in the United States range from a low of about 3,000 to a high of about 49,000 people.”[i]  But on another page of its website, the agency states, “CDC does not know exactly how many people die from seasonal flu each year.[ii] In other words, the CDC aggressively promotes a solution for a problem that it cannot quantify.
What can be more easily quantified is risks associated with the vaccine. On several occasions, flu vaccine programs have been terminated due to side effects. In October 1976, The National Influenza Immunization Program (NIIP) started with about one million vaccinations per week, and grew quickly to four million per week. But within only two months, ten states had reported cases of Guillain-Barre syndrome linked to the vaccine. In December 1976, the program was discontinued.
By January 1977, more than 500 cases of GBS had been reported. Some patients recovered completely, some partially, and 25 people died. The NIIP determined that the risk of developing GBS within 6 weeks was 10 times higher for those receiving a flu vaccine than for unvaccinated people. While this should have been the end of promoting population-wide vaccination for flu until safety could be established, flu vaccine promotion programs continued. In 1992, 1993, and 1994 flu vaccines again were shown to increase the risk of GBS.[iii] [iv] [v]
As of November 2013, there were 93,000 reactions attributed to flu vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) including 1,080 deaths, 8,888 hospitalizations, 1,801 disabilities, and 1,700 cases of Guillian Barre Syndrome.[vi]
According to data from the National Vaccine Injury Compensation Program, the flu shot is the most dangerous vaccine in America. During one reporting period, out of 134 cases settled before the court, 79 were due to the flu shot, and these included three deaths. While the most common injury resulting from flu shots was Guillain-Barre syndrome, others included acute disseminated encephalomyelitis, transverse myelitis, shingles (herpes zoster), neuropathic demyelination, seizures, neuropathy, brachial plexopathy, rheumatoid arthritis, optic neuritis, and Bell's palsy.[vii] 
The adjuvants in flu vaccines, which include mercury (25 mcg), formaldehyde, polyethylene glycol, egg protein, polysorbate 80, MSG, pig gelatin, and antibiotics are equally concerning. Between 2009-2010, fetal deaths reported to VAERS had increased 4,250% just with the addition of Thimerosal to flu vaccines.[viii]
Just as concerning is the efficacy (or lack of efficacy) of the vaccine. A Cochrane review analyzed the impact of flu vaccines on healthy adults including pregnant women and newborns by looking at 90 reports of 116 studies that compared flu vaccines to placebo or no intervention. Combined, the studies included close to ten million people. The group concluded that 40 people would have to be vaccinated to prevent just one case of influenza-like illness (ILI), and 71 people have to be vaccinated to prevent one case of influenza. The vaccine had no effect on the number of working days lost or hospitalization rates. The vaccine also had almost no effect on pregnant women or their newborn babies. Live aerosol vaccine was similarly useless.[ix]
In another review, Cochrane reported that flu vaccines were not effective for the elderly either.[x]
Cochrane conducted a similar review to evaluate the efficacy rates (defined as prevention of confirmed influenza), effectiveness (defined as prevention of influenza-like illness), and adverse events of influenza vaccines in healthy children. The review included 75 studies and showed:
  • Six children under age 6 have to be vaccinated with live attenuated vaccine in order to prevent one case of flu.
  • In all of the studies, there was no useable data for children under the age of two.
  • For children age two or younger, inactivated flu vaccines were no more effective than placebo.
  • In order to prevent one case of influenza in children over the age of six, 28 children need to be vaccinated, and eight need to be vaccinated to prevent just one case of influenza-like illness.
The researchers found “no evidence of effect on secondary cases, lower respiratory tract disease, drug prescriptions, otitis media… (only) weak single study evidence of effect on school absenteeism and caring parents from work.”  In other words, the children had almost no reduction in risk of developing the flu, flu-like illness, or of developing complications from flu. The vaccine was shown to be almost worthless.
Side effects were noted, however, and some were serious such as narcolepsy and febrile convulsions.
The researchers expressed surprise that the current recommendation is to vaccinate healthy children starting at 6 months of age in the U.S. and several other countries based on such limited evidence, and advised that research is needed in order to identify all potential harm resulting from flu vaccines.
Just as important, researchers identified issues concerning study design, funding, and scientific misbehavior. The Cochrane group reported that industry-funded studies showed more positive results than those funded with public money. They reported that “An earlier systematic review of 274 influenza vaccine studies published up to 2007 found industry-funded studies were published in more prestigious journals and cited more than other studies independently from methodological quality and size…the review showed that reliable evidence on influenza vaccines is thin but there is evidence of widespread manipulation of conclusions and spurious notoriety of the studies. The content and conclusions of this review should be interpreted in light of this finding.”[xi]  Translation:  lots of misconduct is required in order to report conclusions that support flu vaccines.
Even the package inserts on the vaccines state that they are not effective. For example, the package insert for FLULAVAL 2013-2014 formula for Influenza subtype A viruses and type B virus states, “…there have been no controlled trials adequately demonstrating a decrease in influenza disease after vaccinations with FLULAVAL.[xii]
Next week, flu vaccines for pregnant women, healthcare workers, and widespread misbehavior in promoting flu vaccines.

[iii] Lasky T, Terracciano G, Magder L, et al. “The Guillain-BarrĂ© syndrome and the 1992-1993 and 1993-1994 influenza vaccines.” NEJM 1998;339(25):1797-802.
[iv] Schonberger L, Bregman D, Sullivan-Bolyai J, et al. “Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977.” Am J Epidemiol  1979; 110(5):105–23.
[v] Geier M, Geier D, Zahalsky A. “Influenza vaccination and Guillain Barre syndrome small star, filled.” Clin Immunol 2003;107(2):116-21.
[ix] Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C. “Vaccines for preventing influenza in healthy adults.” Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD001269. DOI: 10.1002/14651858.CD001269.pub5
[x] Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, Demicheli V. “Vaccines for preventing influenza in the elderly.” Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004876.
[xi] Jefferson T, Rivetti A, Di Piettrantonj C, Demicheli V, FerroniE. “Vaccines for preventing influenza in healthy children.” Cochrane Database Syst Rev August 15 2012 www.ncbi.nlm.nih.gov/pubmed/2289594

No comments:

Post a Comment